We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXTN
626
DELISTED
Exterran Corporation
EXTN
| $1.75M | 0.01% |
368,644
+258,821
| +236% | +$1.11M |
|
627
Amerant Bancorp
AMTB
$1.13B
| $1.75M | 0.01% |
82,006
+68,737
| +518% | +$1.44M |
|
|
TRST
628
Trustco Bank Corp NY
TRST
$978M
| $1.75M | 0.01% |
50,947
-380
| -0.7% | -$14.1K |
|
629
Shenandoah Telecom
SHEN
$632M
| $1.73M | 0.01% |
+35,687
| New | +$1.77M |
|
630
Insulet
PODD
$11.5B
| $1.72M | 0.01% |
6,247
+168
| +3% | +$45.7K |
|
|
MODV
631
DELISTED
ModivCare
MODV
| $1.71M | 0.01% |
10,063
-18,850
| -65% | -$2.82M |
|
632
Resideo Technologies
REZI
$5.25B
| $1.71M | 0.01% |
56,831
+29,005
| +104% | +$859K |
|
633
Astec Industries
ASTE
$1.28B
| $1.7M | 0.01% |
27,068
-8,474
| -24% | -$591K |
|
|
HTB
634
HomeTrust Bancshares
HTB
$834M
| $1.68M | 0.01% |
60,289
+2,227
| +4% | +$61.1K |
|
635
Amdocs
DOX
$5.69B
| $1.67M | 0.01% |
21,539
+16,460
| +324% | +$1.27M |
|
636
Puma Biotechnology
PBYI
$412M
| $1.66M | 0.01% |
180,944
+6,251
| +4% | +$63.3K |
|
637
American Financial Group
AFG
$12B
| $1.66M | 0.01% |
13,302
-13,550
| -50% | -$1.69M |
|
638
Donegal Group Class A
DGICA
$706M
| $1.66M | 0.01% |
113,686
+70,286
| +162% | +$1.08M |
|
639
Minerva Neurosciences
NERV
$191M
| $1.64M | 0.01% |
88,132
-6,512
| -7% | -$140K |
|
640
Paycom
PAYC
$7.17B
| $1.63M | 0.01% |
+4,496
| New | +$1.59M |
|
|
ASRT
641
DELISTED
Assertio
ASRT
| $1.62M | 0.01% |
69,258
+52,153
| +305% | +$1.51M |
|
|
LNW
642
DELISTED
Light & Wonder
LNW
| $1.62M | 0.01% |
20,910
-470,729
| -96% | -$28.9M |
|
643
Byline Bancorp
BY
$1.75B
| $1.61M | 0.01% |
71,270
+60,964
| +592% | +$1.36M |
|
644
Everspin Technologies
MRAM
$341M
| $1.6M | 0.01% |
249,411
+9,875
| +4% | +$56.5K |
|
|
BBBY
645
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.59M | 0.01% |
+47,844
| New | +$1.33M |
|
646
ScottsMiracle-Gro
SMG
$4.03B
| $1.58M | 0.01% |
8,249
-1,401
| -15% | -$309K |
|
647
Financial Institutions
FISI
$809M
| $1.57M | 0.01% |
52,491
+17,352
| +49% | +$542K |
|
648
Allient
ALNT
$1.43B
| $1.57M | 0.01% |
45,492
+15
| +0% | +$528 |
|
649
Phillips 66
PSX
$82.7B
| $1.57M | 0.01% |
+18,291
| New | +$1.54M |
|
|
SCTL
650
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.56M | 0.01% |
676,630
+240,345
| +55% | +$610K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.